TABLE 2.
Group | Time IVM | No. oocytes | GV | MI | MII | DEG | NN |
TCM-199 + FBS | 72 | 73 | 16 (21.9%)a | 24 (32.8%)a | 3 (4.1%)a | 22 (30.1%)a,c | 8 (10.9%)a |
48 | 41 | 8 (19.5%)a | 21 (51.2%)b | 4 (9.7%)a | 3 (7.3%)b | 5 (12.1%)a | |
SOF + BSA + FBS | 72 | 86 | 17 (19.7%)a | 23 (26.9%)a | 6 (6.9%)a | 20 (23.2%)c | 20 (23.2%)b |
48 | 55 | 16 (29%)a | 27 (49%)b | 2 (3.6%)a | 5 (9%)b | 5 (9%)a | |
SOF + BSA | 72 | 78 | 16 (20.5%)a | 21 (26.9%)a | 4 (5.5%)a | 34 (43.5%)a | 3 (4.1%)a |
The percentages of oocytes in the germinal vesicle (GV), metaphase I (MI), metaphase II (MII), degenerated (DEG), and non-identifiable (NN) stages were recorded. In the same column, percentages without the same superscripts differed significantly (a−cp-value < 0.05). The experiments were repeated three times (n = 3).
BSA, bovine serum albumin; FBS, fetal bovine serum; IVM, in vitro maturation; SOF, synthetic oviductal fluid.